EssilorluxotticaESLOF +2.05%82 5-Year Yield-on-Cost % is 10.35 as of Jul. 02, 2026, which is 75% above its 10-year median of 5.90. GuruFocus rates ESLOF with a GF Score™ of 82/100 and a GF Value™ of $263.63 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 328 Medical Devices & Instruments companies, Essilorluxottica ranks better than 89.63% on this metric.
Essilorluxottica's yield on cost for the quarter that ended in Dec. 2025 was 10.35.
The historical rank and industry rank for Essilorluxottica's 5-Year Yield-on-Cost % or its related term are showing as below:
ESLOF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.53 Med: 5.9 Max: 10.49
Current: 10.35
During the past 13 years, Essilorluxottica's highest Yield on Cost was 10.49. The lowest was 2.53. And the median was 5.90.
ESLOF's 5-Year Yield-on-Cost % is ranked better than 89.63% of 328
companies
in the Medical Devices & Instruments industry
Industry Median: 2.425
vs ESLOF: 10.35
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Essilorluxottica 5-Year Yield-on-Cost % Related Terms
ESLOF vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Essilorluxottica's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Essilorluxottica 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Essilorluxottica's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Essilorluxottica's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Essilorluxottica (ESLOF) has a 5-Year Yield-on-Cost % of 10.35 as of Jul. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Essilorluxottica and its competitors. This is 75% above median its historical median of 5.90. Over the past decade, Essilorluxottica's 5-Year Yield-on-Cost % has ranged from 2.53 to 10.49. According to the industry distribution chart, Essilorluxottica ranks #34 out of 328 companies in the Medical Devices & Instruments industry, placing it in the top 10.4%.
Is Essilorluxottica's 5-Year Yield-on-Cost % too high?
Essilorluxottica's current 5-Year Yield-on-Cost % of 10.35 is 75% above median its 10-year median of 5.90. Over the past 10 years, this metric has ranged from a low of 2.53 to a high of 10.49. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.43. Essilorluxottica's value of 10.35 is 326.8% above this industry median. Based on the distribution chart, Essilorluxottica ranks #34 out of 328 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Essilorluxottica has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Essilorluxottica's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Essilorluxottica ranks #34 out of 328 companies for 5-Year Yield-on-Cost %. This places Essilorluxottica in the top 10% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.43. Essilorluxottica's value of 10.35 is 326.8% above this benchmark. Historically, Essilorluxottica's own 5-Year Yield-on-Cost % has ranged from 2.53 to 10.49 over the past decade. While the company's 10-year median is 5.90 vs. the industry median of 2.43, Essilorluxottica has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.43, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Essilorluxottica's current 5-Year Yield-on-Cost % of 10.35 is 326.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Essilorluxottica and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Essilorluxottica's current 5-Year Yield-on-Cost % is 10.35, which is 75% above median its own 10-year median of 5.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Essilorluxottica stock overvalued right now?
Based on GuruFocus' analysis, Essilorluxottica (ESLOF) is currently considered Modestly Undervalued. The stock's GF Value™ is $263.63, compared to a current price of $197.64 — trading 25% below its estimated fair value. The current 5-Year Yield-on-Cost % is 10.35, which is 75% above median its 10-year median of 5.90 and 326.8% above the Medical Devices & Instruments industry median of 2.43. Essilorluxottica's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Essilorluxottica (ESLOF), the current 5-Year Yield-on-Cost % is 10.35 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Essilorluxottica (ESLOF) Overvalued in 2026?
Based on GuruFocus' analysis, Essilorluxottica stock appears to be undervalued.
The current stock price of $197.64 is trading 25% below its estimated GF Value™ of $263.63.
GuruFocus considers Essilorluxottica to be Modestly Undervalued.
Key valuation signals for ESLOF:
5-Year Yield-on-Cost %: 10.35 (75% above median its 10-year median of 5.90)
GF Value™: $263.63 vs. price of $197.64 (25% below fair value)
Industry Position: 326.8% above the Medical Devices & Instruments median (#34 of 328)
No single metric tells the full story. See the ESLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest competitor and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 37% of sales in Europe, 45% in North America, and the rest in Asia and Latin America.
82GF Score
Get the complete analysis for ESLOF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESLOF has been successfully added to your 